11. Hematology and oncology clinical care during the coronavirus disease 2019 pandemic. (14th July 2020) Authors: Shah, Manish A.; Emlen, M. Frances; Shore, Tsiporah; Mayer, Sebastian; Leonard, John P.; Rossi, Adriana; Martin, Peter; Ritchie, Ellen; Niesvizky, Ruben; Pastore, Raymond; Cigler, Tessa; De Sancho, Maria; Scheff, Ronald; Van Besien, Koen; Roboz, Gail; Nanus, David; Goldstein, Paula; Scrimenti, La... Journal: CA Issue: Volume 70:Number 5(2020) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Q and A. Issue 4 (23rd April 2023) Authors: Rajdev, Lakshmi; Kennedy, Erin B.; Shah, Manish A. Journal: JCO oncology practice Issue: Volume 19:Issue 4(2023) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. Issue 7 (1st March 2023) Authors: Shah, Manish A.; Kennedy, Erin B.; Alarcon-Rozas, Ashley E.; Alcindor, Thierry; Bartley, Angela N.; Malowany, Aubrey Belk; Bhadkamkar, Nishin A.; Deighton, Dana C.; Janjigian, Yelena; Karippot, Asha; Khan, Uqba; King, Daniel A.; Klute, Kelsey; Lacy, Jill; Lee, James J.; Mehta, Rutika; Mukherjee, ... Journal: Journal of clinical oncology Issue: Volume 41:Issue 7(2023) Page Start: 1470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update. Issue 28 (1st October 2021) Authors: Shah, Manish A.; Hofstetter, Wayne L.; Kennedy, Erin B. Journal: Journal of clinical oncology Issue: Volume 39:Issue 28(2021) Page Start: 3182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies. Issue 2 (March 2018) Authors: Choe, Hannah K.; De Sancho, Maria T.; Kim, Sunnie S.; Dai, Tong; Shah, Manish A. Journal: Blood coagulation and fibrinolysis Issue: Volume 29:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1). Issue 9 (20th March 2021) Authors: Shah, Manish A.; Bodoky, Gyorgy; Starodub, Alexander; Cunningham, David; Yip, Desmond; Wainberg, Zev A.; Bendell, Johanna; Thai, Dung; He, Joyce; Bhargava, Pankaj; Ajani, Jaffer A. Journal: Journal of clinical oncology Issue: Volume 39:Issue 9(2021) Page Start: 990 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer. (2nd November 2019) Authors: Khan, Uqba; Shah, Manish A. Journal: Expert opinion on biological therapy Issue: Volume 19:Number 11(2019) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Redefining Intermediate-Stage HCC Treatment in the Era of Immune Therapies. Issue 1 (January 2022) Authors: Brar, Gagandeep; Kesselman, Andrew; Malhotra, Anuj; Shah, Manish A. Journal: JCO oncology practice Issue: Volume 18:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Reply to K. de Joode et al. Issue 9 (20th March 2021) Authors: Brar, Gagandeep; Pinheiro, Laura C.; Hidalgo, Manuel; Shah, Manish A. Journal: Journal of clinical oncology Issue: Volume 39:Issue 9(2021) Page Start: 1093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study. (17th September 2020) Authors: Bendell, Johanna; Sharma, Sunil; Patel, Manish R.; Windsor, Kevin S.; Wainberg, Zev A.; Gordon, Michael; Chaves, Jorge; Berlin, Jordan; Brachmann, Carrie Baker; Zavodovskaya, Marianna; Liu, JieJane; Thai, Dung; Bhargava, Pankaj; Shah, Manish A.; Khan, Saad A.; Starodub, Alexander Journal: Oncologist Issue: Volume 25:Number 11(2020) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗